abstract |
The present invention provides MDM2 inhibitor compounds of formula (I), wherein the variables are as defined herein, which are useful as therapeutic agents, in particular for the treatment of cancer. The invention also relates to pharmaceutical compositions containing MDM2 inhibitors. |